Chat with us, powered by LiveChat

Balanced Bridge Blog

Taxotere Lawsuit Update 2022

Taxotere Lawsuit Update 2022 – Judge Allows New Trial to Go forward in Class Action Lawsuit.

Taxotere lawsuit update 2022. One of the fastest growing cases in the pharmaceutical space concerns the cancer drug Taxotere.

Taxotere Vision Damage Lawsuits

Taxotere lawsuit update 2022. Taxotere is a breast cancer chemotherapy drug which initially hit the news when women started experiencing permanent hair loss from the drug. But more recently, there have been a flood of product liability cases due to women alleging Taxotere caused permanent vision damage.

There is already an MDL with approximately 12,000 Taxotere hair loss related lawsuits. This new vision damage litigation is separate. As a result, these lawsuits will be consolidated into its own MDL.

Balanced Bridge provides post settlement advances for both attorneys and plaintiffs. We advance in situations where an agreement has been reached, but there will be some delay until contingency fees and settlement awards are distributed. We can help once someone reaches a Taxotere settlement, or it can be on other cases.

For attorneys with delayed contingency fees – CLICK HERE TO LEARN MORE.

For plaintiffs with delayed settlement awards – CLICK HERE TO LEARN MORE.

Use of Taxotere as a Cancer Treatment

Taxotere lawsuit update 2022. Taxotere, also known as docetaxel, was approved by the U.S. Food & Drug Administration to treat a variety of cancers, including breast cancer, prostate cancer, some lung cancers and head and neck cancer. The drug is manufactured by Sanofi-Aventis and is often used in conjunction with other drugs and therapies.

Like many chemotherapy drugs, various side effects were common with Taxotere including low blood cell count, nausea and vomiting and hair loss. However, marketing for the drug focused on it being safer and more effective than other types of treatments.

Taxotere and Permanent Hair Loss

Hair loss is a noted side effect of many types of chemotherapy treatments, but most patients regrow their hair back within six months after completion.

Some women who used Taxotere as part of breast cancer treatment began experiencing permanent hair loss (alopecia) upon completion of their treatments, even though Sanofi-Aventis didn’t initially warn about this as a potential side effect.

The drug was introduced on the market in the mid-1990’s, and studies from as far back as the late 1990’s showed links between permanent hair loss and the use of Taxotere, indicating 10% or more of patients could experience such side effects. Sanofi-Aventis did not include warnings about such problems until 2015.

2022 Update: Taxotere lawsuit allowed to go forward by judge.

Learn more about Balanced Bridge’s post settlement funding options for attorneys.

Learn more about Balanced Bridge’s plaintiff post settlement funding options.

Taxotere Litigation

Women devastated by the permanent hair loss caused by Taxotere began filing claims against Sanofi-Aventis accusing the manufacturer of false claims and negligence in failing to adequately warn about such side effects.

In late 2016, an MDL was established in the U.S. District Court in Eastern Louisiana with future trials being heard by Judge Kurt D. Engelhardt. Within a year, almost 2,000 claims were filed within the MDL and the case has continued to grow exponentially, with around 12,000 claims pending by the beginning of 2019.

Taxotere lawsuit update 2022. While there is no news of any settlements yet in these cases, a series of bellwether trials involving the hair loss litigation took place. Both cases, one in 2019 and one in 2021, resulted in defense verdicts. It remains to be seen if Sanofi-Aventis will attempt negotiations to arrive at some global settlement agreement, given the rapid rise in claims against them involving Taxotere.

Balanced Bridge Can Help With Post Settlement Advances When Taxotere Cases Settle Or On Other Delayed, Settled Cases

Balanced Bridge specializes in post settlement funding solutions for attorneys.

Balanced Bridge can also provide post settlement funding solutions for plaintiffs.

Once plaintiffs begin to receive settlements in their Taxotere cases, Balanced Bridge would be in position to provide advances against those pending awards and also against pending attorney fees for claimants or attorneys who can’t afford to wait until distribution.

We can also fund other cases that experience any distribution delays after an agreement has been reached.

To learn more about how our legal funding solutions help with delayed settlements, you can browse through our website or call us at 267-457-4540 to speak directly with a legal funding specialist. Balanced Bridge is happy to answer any questions you may have and discuss the funding process in more detail.

Share via
Copy link
Powered by Social Snap